Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Zein Beta-Cyclodextrin Micropowders for Iron Bisglycinate Delivery.

Esposito D, Dal Poggetto G, Demont A, Kraut N, Miro A, Ungaro F, Laurienzo P, Quaglia F.

Pharmaceutics. 2020 Jan 11;12(1). pii: E60. doi: 10.3390/pharmaceutics12010060.

2.

PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection.

Costabile G, Provenzano R, Azzalin A, Scoffone VC, Chiarelli LR, Rondelli V, Grillo I, Zinn T, Lepioshkin A, Savina S, Miro A, Quaglia F, Makarov V, Coenye T, Brocca P, Riccardi G, Buroni S, Ungaro F.

Nanomedicine. 2020 Jan;23:102113. doi: 10.1016/j.nano.2019.102113. Epub 2019 Oct 25.

3.

Surface Exposure of PEG and Amines on Biodegradable Nanoparticles as a Strategy to Tune Their Interaction with Protein-Rich Biological Media.

Conte C, Dal Poggetto G, J Swartzwelter B, Esposito D, Ungaro F, Laurienzo P, Boraschi D, Quaglia F.

Nanomaterials (Basel). 2019 Sep 20;9(10). pii: E1354. doi: 10.3390/nano9101354.

4.

Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity.

Conte C, Moret F, Esposito D, Dal Poggetto G, Avitabile C, Ungaro F, Romanelli A, Laurienzo P, Reddi E, Quaglia F.

Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:876-886. doi: 10.1016/j.msec.2019.04.054. Epub 2019 Apr 30.

PMID:
31147059
5.

Poly(lactide- co-glycolide) Nanoparticles for Prolonged Therapeutic Efficacy of Esculentin-1a-Derived Antimicrobial Peptides against Pseudomonas aeruginosa Lung Infection: in Vitro and in Vivo Studies.

Casciaro B, d'Angelo I, Zhang X, Loffredo MR, Conte G, Cappiello F, Quaglia F, Di YP, Ungaro F, Mangoni ML.

Biomacromolecules. 2019 May 13;20(5):1876-1888. doi: 10.1021/acs.biomac.8b01829. Epub 2019 Apr 23.

PMID:
31013061
6.

In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery.

Pellosi DS, d'Angelo I, Maiolino S, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Quaglia F, Ungaro F.

Eur J Pharm Biopharm. 2018 Sep;130:30-38. doi: 10.1016/j.ejpb.2018.06.006. Epub 2018 Jun 19.

PMID:
29890256
7.

Improving in vivo conversion of oleuropein into hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v and an Olea europaea standardized extract.

Aponte M, Ungaro F, d'Angelo I, De Caro C, Russo R, Blaiotta G, Dal Piaz F, Calignano A, Miro A.

Int J Pharm. 2018 May 30;543(1-2):73-82. doi: 10.1016/j.ijpharm.2018.03.013. Epub 2018 Mar 8.

PMID:
29526619
8.

Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier.

d'Angelo I, Costabile G, Durantie E, Brocca P, Rondelli V, Russo A, Russo G, Miro A, Quaglia F, Petri-Fink A, Rothen-Rutishauser B, Ungaro F.

J Aerosol Med Pulm Drug Deliv. 2018 Jun;31(3):170-181. doi: 10.1089/jamp.2017.1364. Epub 2017 Oct 16.

PMID:
29035132
9.

Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(ε-caprolactone) diblock copolymers: Beyond a paradigm.

Venuta A, Moret F, Dal Poggetto G, Esposito D, Fraix A, Avitabile C, Ungaro F, Malinconico M, Sortino S, Romanelli A, Laurienzo P, Reddi E, Quaglia F.

Eur J Pharm Sci. 2018 Jan 1;111:177-185. doi: 10.1016/j.ejps.2017.09.048. Epub 2017 Sep 28.

10.

Poly(ethylene oxide)/hydroxypropyl-β-cyclodextrin films for oromucosal delivery of hydrophilic drugs.

d'Angelo I, Fraix A, Ungaro F, Quaglia F, Miro A.

Int J Pharm. 2017 Oct 15;531(2):606-613. doi: 10.1016/j.ijpharm.2017.06.029. Epub 2017 Jun 12.

PMID:
28619453
11.

Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.

Russo A, Maiolino S, Pagliara V, Ungaro F, Tatangelo F, Leone A, Scalia G, Budillon A, Quaglia F, Russo G.

Oncotarget. 2016 Nov 29;7(48):79670-79687. doi: 10.18632/oncotarget.13216.

12.

Nanoassemblies based on non-ionic amphiphilic cyclodextrin hosting Zn(II)-phthalocyanine and docetaxel: Design, physicochemical properties and intracellular effects.

Conte C, Scala A, Siracusano G, Sortino G, Pennisi R, Piperno A, Miro A, Ungaro F, Sciortino MT, Quaglia F, Mazzaglia A.

Colloids Surf B Biointerfaces. 2016 Oct 1;146:590-7. doi: 10.1016/j.colsurfb.2016.06.047. Epub 2016 Jun 28.

PMID:
27424090
13.

Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.

Russo A, Pellosi DS, Pagliara V, Milone MR, Pucci B, Caetano W, Hioka N, Budillon A, Ungaro F, Russo G, Quaglia F.

Int J Pharm. 2016 Sep 10;511(1):127-139. doi: 10.1016/j.ijpharm.2016.06.118. Epub 2016 Jun 29.

PMID:
27374195
14.

Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections.

d'Angelo I, Perfetto B, Costabile G, Ambrosini V, Caputo P, Miro A, d'Emmanuele di Villa Bianca R, Sorrentino R, Donnarumma G, Quaglia F, Ungaro F.

Biomacromolecules. 2016 May 9;17(5):1561-71. doi: 10.1021/acs.biomac.5b01646. Epub 2016 Apr 1.

PMID:
27002689
15.

Cyclodextrin-assisted assembly of PEGylated polyester nanoparticles decorated with folate.

Conte C, Fotticchia I, Tirino P, Moret F, Pagano B, Gref R, Ungaro F, Reddi E, Giancola C, Quaglia F.

Colloids Surf B Biointerfaces. 2016 May 1;141:148-157. doi: 10.1016/j.colsurfb.2016.01.035. Epub 2016 Jan 22.

PMID:
26852098
16.

PLGA carriers for inhalation: where do we stand, where are we headed?

d'Angelo I, Quaglia F, Ungaro F.

Ther Deliv. 2015;6(10):1139-44. doi: 10.4155/tde.15.37. Epub 2015 Oct 8. No abstract available.

PMID:
26606854
17.

Polymeric Nanoparticles for Cancer Photodynamic Therapy.

Conte C, Maiolino S, Pellosi DS, Miro A, Ungaro F, Quaglia F.

Top Curr Chem. 2016;370:61-112. doi: 10.1007/978-3-319-22942-3_3. Review.

PMID:
26589506
18.

Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide.

d'Angelo I, Casciaro B, Miro A, Quaglia F, Mangoni ML, Ungaro F.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:717-25. doi: 10.1016/j.colsurfb.2015.08.027. Epub 2015 Aug 22.

PMID:
26340361
19.

Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin.

Conte C, Costabile G, d'Angelo I, Pannico M, Musto P, Grassia G, Ialenti A, Tirino P, Miro A, Ungaro F, Quaglia F.

J Colloid Interface Sci. 2015 Sep 15;454:112-20. doi: 10.1016/j.jcis.2015.05.010. Epub 2015 May 14.

PMID:
26004575
20.

Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.

Costabile G, d'Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Miro A, Quaglia F, Imperi F, Leoni L, Ungaro F.

Mol Pharm. 2015 Aug 3;12(8):2604-17. doi: 10.1021/acs.molpharmaceut.5b00098. Epub 2015 May 27.

PMID:
25974285

Supplemental Content

Loading ...
Support Center